Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. lowered its position in Silicon Laboratories Inc. (NASDAQ:SLAB) by 1.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 6,006 shares of the semiconductor company’s stock after selling 83 shares during the period. Victory Capital Management Inc.’s holdings in Silicon Laboratories were worth $746,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of SLAB. Jones Financial Companies Lllp raised its holdings in Silicon Laboratories by 44.5% in the 4th quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 69 shares during the period. Advisors Asset Management Inc. raised its stake in shares of Silicon Laboratories by 159.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 275 shares of the semiconductor company’s stock worth $32,000 after buying an additional 169 shares during the period. Venturi Wealth Management LLC raised its stake in shares of Silicon Laboratories by 207.0% during the 4th quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company’s stock worth $98,000 after buying an additional 530 shares during the period. Asset Management One Co. Ltd. acquired a new position in shares of Silicon Laboratories during the 4th quarter worth approximately $117,000. Finally, KBC Group NV raised its position in Silicon Laboratories by 42.1% during the fourth quarter. KBC Group NV now owns 1,279 shares of the semiconductor company’s stock worth $159,000 after acquiring an additional 379 shares during the period.

Silicon Laboratories Stock Performance

NASDAQ:SLAB opened at $123.57 on Friday. Silicon Laboratories Inc. has a one year low of $94.00 and a one year high of $160.00. The stock has a market cap of $4.01 billion, a PE ratio of -20.80 and a beta of 1.15. The stock has a 50 day moving average price of $138.03 and a 200 day moving average price of $123.05.

Silicon Laboratories (NASDAQ:SLAB) last issued its earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.11). Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The business had revenue of $166.25 million during the quarter, compared to the consensus estimate of $166.09 million. During the same period last year, the company earned ($1.19) EPS. The company’s revenue for the quarter was up 91.4% on a year-over-year basis. As a group, analysts predict that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have weighed in on SLAB. Barclays upped their price objective on shares of Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a research report on Friday, January 17th. Needham & Company LLC restated a “buy” rating and set a $150.00 price target on shares of Silicon Laboratories in a research report on Wednesday, March 12th. Benchmark reissued a “buy” rating and set a $160.00 target price on shares of Silicon Laboratories in a report on Wednesday, March 12th. StockNews.com raised Silicon Laboratories from a “sell” rating to a “hold” rating in a report on Tuesday. Finally, KeyCorp increased their price objective on Silicon Laboratories from $115.00 to $160.00 and gave the company an “overweight” rating in a research note on Wednesday, January 22nd. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $136.20.

Insider Activity at Silicon Laboratories

In other news, Director Navdeep S. Sooch sold 2,360 shares of the stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $149.00, for a total transaction of $351,640.00. Following the completion of the transaction, the director now directly owns 400,567 shares in the company, valued at approximately $59,684,483. This represents a 0.59 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director William G. Bock sold 1,000 shares of the stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $149.43, for a total value of $149,430.00. Following the transaction, the director now owns 31,115 shares of the company’s stock, valued at approximately $4,649,514.45. This represents a 3.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 5,360 shares of company stock valued at $782,610. 1.72% of the stock is owned by company insiders.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.